Replies to post #158176 on Avid Bioservices Inc (CDMO)

[biopharm]

CP.. question about this move from $2+ and now down to current levels..

Is it possible, that once we hit $2 and several brokerages allowed many to borrow on margin--- that margin was granted ( even maybe some of those accounts out there that called and requested to "not" have their shares shorted ) ... but a pause, because many expect this to follow last years trend but don't have the exact timing down.

So some may say the hell with it and go on margin, but more shares.... but this of course now allows those shares to be shorted? ( I think that is correct ). Finally, the powers to be see this and want to keep the stock price down well below that "margin" magic number of possibly $2 and wait for some shares to be shaken and sold out and scooped up. Once the powers to be feel they have all those shares possible from this little shake down, the price will move back up as there are no more shares to be had.

But... its those that opened up margin accounts "again"... that could be affecting the downward pressure as their shares are eligible to become part of another groups will to short and play the game?

Hopefully I am understanding this correctly.

[edcpf]

With 100M+ volume since fast track we can have a similar amount of volume in roughly a week after the next round of major news, with the shares being in great demand after the first round of accumulation. The news will come since this newfound popularity is something the company wants to hold on to, and capitalize on that. Besides, they will need to release material news anyway.

On Aug 27th 2012, I believe the uptick rule some are speaking here about took effect (if it's -10% we're speaking about) with accumulation continuing at full steam on the next day.

Now, taking price number out of the equation. As a curious fact, the market cap was quite similar in 2012, however the fluctuations probably due to lower outstanding shares were wider, with the first high close being 302.12M on 17th August 2012 and dipping below 200M (194.81M) on 27th before its run to 561.59M on September 7th, powered by a series of news. The shorts are feeding on the absence of news currently.

With all the new understanding behind Bavituximab and recent news, even the 2013 conservative accumulation market cap of 200M will have to get beaten by 300M, which means we are bound to stay around $2 area. And as we know the new conservative market cap will be at least an order of magnitude (that's 10x) higher once major material news are released, which will at least start looking like it wants to come to true value.

I'm looking at between one and two orders of magnitude from this point on, depending on developments, accumulating and making no shares available for shorting.